Marinomed Biotech AG (MARI.VI)
EUR 12.0
(-2.83%)
EUR 12.0
(-2.83%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 9.18 Million EUR | -18.56% |
| 2022 | 11.27 Million EUR | -3.03% |
| 2021 | 11.62 Million EUR | 43.12% |
| 2020 | 8.12 Million EUR | 32.22% |
| 2019 | 6.14 Million EUR | 31.68% |
| 2018 | 4.66 Million EUR | -3.01% |
| 2017 | 4.81 Million EUR | 84.45% |
| 2016 | 2.6 Million EUR | 17.72% |
| 2015 | 2.21 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 737.5 Thousand EUR | -63.62% |
| 2023 FY | 9.18 Million EUR | -18.56% |
| 2023 Q1 | 3.31 Million EUR | -20.62% |
| 2023 Q2 | 1.9 Million EUR | -42.47% |
| 2023 Q3 | 1.92 Million EUR | 0.97% |
| 2023 Q4 | 2.02 Million EUR | 5.13% |
| 2022 Q1 | 2.41 Million EUR | -59.22% |
| 2022 FY | 11.27 Million EUR | -3.03% |
| 2022 Q4 | 4.18 Million EUR | 90.45% |
| 2022 Q3 | 2.19 Million EUR | -11.77% |
| 2022 Q2 | 2.48 Million EUR | 3.17% |
| 2021 Q1 | 2.21 Million EUR | -27.61% |
| 2021 Q3 | 2.5 Million EUR | 150.65% |
| 2021 Q4 | 5.91 Million EUR | 136.53% |
| 2021 FY | 11.62 Million EUR | 43.12% |
| 2021 Q2 | 997.4 Thousand EUR | -55.02% |
| 2020 Q1 | 1.01 Million EUR | -64.16% |
| 2020 Q3 | 2.77 Million EUR | 119.03% |
| 2020 Q4 | 3.06 Million EUR | 10.23% |
| 2020 FY | 8.12 Million EUR | 32.22% |
| 2020 Q2 | 1.26 Million EUR | 25.13% |
| 2019 Q2 | 906.89 Thousand EUR | 20.72% |
| 2019 Q1 | 751.22 Thousand EUR | -47.59% |
| 2019 Q4 | 2.82 Million EUR | 70.7% |
| 2019 FY | 6.14 Million EUR | 31.68% |
| 2019 Q3 | 1.65 Million EUR | 82.75% |
| 2018 Q1 | 922.21 Thousand EUR | -49.5% |
| 2018 FY | 4.66 Million EUR | -3.01% |
| 2018 Q4 | 1.43 Million EUR | -16.55% |
| 2018 Q3 | 1.71 Million EUR | 189.74% |
| 2018 Q2 | 592.85 Thousand EUR | -35.71% |
| 2017 Q4 | 1.82 Million EUR | 0.0% |
| 2017 FY | 4.81 Million EUR | 84.45% |
| 2016 FY | 2.6 Million EUR | 17.72% |
| 2015 FY | 2.21 Million EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|